Sectors
LIMN
Liminatus Pharma, Inc. Class A Common Stock
0.12
9 x 0.12
1 x 0.13
bid
ask
+
0.00
3.68%
10:02 AM
timesize
| Ytd | -79.66% | |
| 1y | -97.85% |
0.12
day range
0.12
0.10
52 week range
9.38
| Open | 0.12 | Prev Close | 0.12 | Low | 0.12 | High | 0.12 | Mkt Cap | 3.21M |
| Vol | 1.77M | Avg Vol | 30.93M | EPS | -0.18 | P/E | -0.66 | Forward P/E | N/A |
| Beta | 5.62 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.15 | 200-d Avg | 0.57 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 1.10M | ||
| Research and Development Expense | 400.00K | ||
| Selling, General and Administrative Expense | 700.90K | ||
| Operating Income | -1.10M | ||
| Interest Expense | 18.64K | ||
| Net Income | -1.12M | ||
| Net Income Common Stock | -1.12M | ||
| Net Income Common Stock (USD) | -1.12M | ||
| Consolidated Income | -1.12M | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -1.11M | ||
| Earning Before Interest & Taxes (USD) | -1.11M | ||
| Weighted Average Shares | 36.00M | ||
| Weighted Average Shares Diluted | 36.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.91M | ||
| Cash and Equivalents (USD) | 1.91M | ||
| Current Assets | 2.78M | ||
| Property, Plant & Equipment Net | 11.70K | ||
| Total Assets | 2.79M | ||
| Debt Current | 1.44M | ||
| Total Debt | 1.44M | ||
| Current Liabilities | 2.89M | ||
| Total Liabilities | 2.92M | ||
| Accumulated Retained Earnings (Deficit) | -40.00M | ||
| Shareholders Equity | -132.60K | ||
| Shareholders Equity (USD) | -132.60K | ||
| Assets Non-Current | 11.70K | ||
| Total Debt (USD) | 1.44M | ||
| Liabilities Non-Current | 33.42K | ||
| Trade and Non-Trade Payables | 724.37K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 518.00 | ||
| Net Cash Flow from Financing | 3.59M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.57M | ||
| Issuance (Purchase) of Equity Shares | 3.59M | ||
| Net Cash Flow from Operations | -2.02M | ||